Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.22 -0.42 (-2.25%)
At close: Sep 30, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) posted Other Non-Current Assets of $146.15 million for Q2 2026, up 75.8% from $83.14 million a year earlier but down 3.8% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Sarepta Therapeutics' Other Non-Current Assets came in at $155.55 million, up 94.6% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
  • In prior years, Sarepta Therapeutics' Other Non-Current Assets was $79.92 million in FY2024 (-41.6%), $136.77 million in FY2023 (-16.1%), $162.97 million in FY2022 (-44.4%) and $292.95 million in FY2021 (+43.8%).
  • Quarterly Other Non-Current Assets has run from a low of $15.58 million in Q1 2024 to a high of $293.12 million in Q3 2022 over five years.
  • On a year-over-year basis, Other Non-Current Assets has increased in each of the last four quarters, with growth averaging 156.0% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q1 2026, with growth of 875.4%; the weakest was Q1 2024, with a decline of 90.4%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $151.96 million (Q1 2026), $155.55 million (Q4 2025) and $73.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Sarepta Therapeutics 1.92 Bn -1.31 Bn 251.87 Mn 146.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 146.15 Mn
Mar 31, 2026 151.96 Mn
Dec 31, 2025 155.55 Mn
Sep 30, 2025 73.38 Mn
Jun 30, 2025 83.14 Mn
Mar 31, 2025 15.58 Mn
Dec 31, 2024 79.92 Mn
Sep 30, 2024 15.58 Mn
Jun 30, 2024 135.73 Mn
Mar 31, 2024 15.58 Mn
Dec 31, 2023 136.77 Mn
Sep 30, 2023 136.93 Mn
Jun 30, 2023 163.04 Mn
Mar 31, 2023 162.39 Mn
Dec 31, 2022 162.97 Mn
Sep 30, 2022 293.12 Mn
Jun 30, 2022 284.20 Mn
Mar 31, 2022 278.65 Mn
Dec 31, 2021 292.95 Mn
Sep 30, 2021 190.79 Mn
API Access

Sarepta Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SRPT&period=max&api_key=YOUR_API_KEY